Bax:Bcl2 Cancer Research Results

Bax:Bcl2, Bax:Bcl2 ratio: Click to Expand ⟱
Source:
Type:
Bax and Bcl-2 are the major members of Bcl-2 family that play a key role in tumor progression or inhibition of intrinsic apoptotic pathway triggered by mitochondrial dysfunction.
Bax/Bcl-2 ratio is typically significantly lower in tumors.


Scientific Papers found: Click to Expand⟱
2327- 2DG,    2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents
- Review, Var, NA
Glycolysis↓, HK2↓, mt-ROS↑, AMPK↑, PPP↓, NADPH↓, GSH↓, Bax:Bcl2↑, Apoptosis↑, RadioS↑, eff↓, Half-Life↓, other↝, eff↓,
1295- AG,  Cisplatin,    Chemosensitizing Effect of Astragalus Polysaccharides on Nasopharyngeal Carcinoma Cells by Inducing Apoptosis and Modulating Expression of Bax/Bcl-2 Ratio and Caspases
- in-vivo, Laryn, NA
AntiTum↑, Apoptosis↑, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, Bax:Bcl2↑,
334- AgNPs,    Silver-Based Nanoparticles Induce Apoptosis in Human Colon Cancer Cells Mediated Through P53
- in-vitro, Colon, HCT116
Bax:Bcl2↑, P53↑, P21↑, Casp3↑, Casp8↑, Casp9↑, Akt↓, NF-kB↓, DNAdam↑, TumCCA↑,
377- AgNPs,    Anticancer Action of Silver Nanoparticles in SKBR3 Breast Cancer Cells through Promotion of Oxidative Stress and Apoptosis
- in-vitro, BC, SkBr3
ROS↑, Apoptosis↑, Bax:Bcl2↑, VEGF↑, Akt↓, PI3K↓, TAC↓, TOS↑, OSI↑, MDA↑, Casp3↑, Casp7↑,
254- AL,    Allicin and Cancer Hallmarks
- Review, Var, NA
NRF2⇅, BAX↑, Bcl-2↓, Fas↑, MMP↓, Bax:Bcl2↑, Cyt‑c↑, Casp3↑, Casp12↑, GSH↓, TumCCA↑, ROS↑, antiOx↓,
261- ALA,    The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells
- in-vitro, BC, MCF7
ROS↓, Akt↓, p27/CDKN1B↑, Bax:Bcl2↑,
1078- And,    Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway
- in-vitro, BC, MDA-MB-231 - in-vitro, Nor, HUVECs - in-vivo, BC, MCF7 - in-vitro, BC, T47D - in-vitro, BC, BT549 - in-vitro, BC, MDA-MB-361
TumCP↓, COX2/PTGS2↓, *angioG↓, Cyt‑c↑, CREB2↓, cFos↓, NF-kB↓, HATs↓, cl‑Casp3↑, cl‑Casp9↑, Bax:Bcl2↑, Apoptosis↑, *toxicity↓,
6396- ANE,  FEO,    Anethole Inhibits the Proliferation of Human Prostate Cancer Cells via Induction of Cell Cycle Arrest and Apoptosis
- in-vitro, Pca, PC3
TumCP↓, TumCG↓, TumCMig↓, CSCs↓, ROS↑, MPT↑, Casp3↑, Casp9↑, DNAdam↑, cl‑PARP↑, Bax:Bcl2↑, TumCCA↑, cycD1/CCND1↓, CDK4↓, cMyc↓, P21↑, p27/CDKN1B↑, NF-kB↓, eff↑,
416- Api,    In Vitro and In Vivo Anti-tumoral Effects of the Flavonoid Apigenin in Malignant Mesothelioma
- vitro+vivo, NA, NA
Bax:Bcl2↑, P53↑, ROS↑, Casp9↑, Casp8↑, cl‑PARP1↑, p‑ERK⇅, p‑JNK↓, p‑p38↑, p‑Akt↓, cJun↓, NF-kB↓, EGFR↓, TumCCA↑,
2639- Api,    Plant flavone apigenin: An emerging anticancer agent
- Review, Var, NA
*antiOx↑, *Inflam↓, AntiCan↑, ChemoSen↑, BioEnh↑, chemoPv↑, IL6↓, STAT3↓, NF-kB↓, IL8↓, eff↝, Akt↓, PI3K↓, HER2/EBBR2↓, cycD1/CCND1↓, CycD3↓, p27/CDKN1B↑, FOXO3↑, STAT3↓, MMP2↓, MMP9↓, VEGF↓, Twist↓, MMP↓, ROS↑, NADPH↑, NRF2↓, SOD↓, COX2/PTGS2↓, p38↑, Telomerase↓, HDAC↓, HDAC1↓, HDAC3↓, Hif1a↓, angioG↓, uPA↓, Ca+2↑, Bax:Bcl2↑, Cyt‑c↑, Casp9↑, Casp12↑, Casp3↑, cl‑PARP↑, E-cadherin↑, β-catenin/ZEB1↓, cMyc↓, CDK4↓, CDK2↓, CDK6↓, IGF-1↓, CK2↓, CSCs↓, FAK↓, Gli↓, GLUT1↓,
2640- Api,    Apigenin: A Promising Molecule for Cancer Prevention
- Review, Var, NA
chemoPv↑, ITGB4↓, TumCI↓, TumMeta↓, Akt↓, ERK↓, p‑JNK↓, *Inflam↓, *PKCδ↓, *MAPK↓, EGFR↓, CK2↓, TumCCA↑, CDK1↓, P53↓, P21↑, Bax:Bcl2↑, Cyt‑c↑, APAF1↑, Casp↑, cl‑PARP↑, VEGF↓, Hif1a↓, IGF-1↓, IGFBP3↑, E-cadherin↑, β-catenin/ZEB1↓, HSPs↓, Telomerase↓, FASN↓, MMPs↓, HER2/EBBR2↓, CK2↓, eff↑, AntiAg↑, eff↑, FAK↓, ROS↑, Bcl-2↓, Cyt‑c↑, cl‑Casp3↑, cl‑Casp7↑, cl‑Casp8↑, cl‑Casp9↑, cl‑IAP2/BIRC3↑, AR↓, PSA↓, p‑pRB↓, p‑GSK‐3β↓, CDK4↓, ChemoSen↑, Ca+2↑, cal2↑,
1151- Api,    Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study
- in-vitro, Pca, PC3 - in-vitro, Pca, 22Rv1 - in-vivo, NA, NA
TumCCA↑, Apoptosis↑, HDAC↓, P21↑, BAX↑, TumCG↓, Bcl-2↓, Bax:Bcl2↑, HDAC1↓, HDAC3↓,
1548- Api,    A comprehensive view on the apigenin impact on colorectal cancer: Focusing on cellular and molecular mechanisms
- Review, Colon, NA
*BioAv↓, *Half-Life∅, selectivity↑, *toxicity↓, Wnt/(β-catenin)↓, P53↑, P21↑, PI3K↓, Akt↓, mTOR↓, TumCCA↑, TumCI↓, TumCMig↓, STAT3↓, PKM2↓, EMT↓, cl‑PARP↑, Casp3↑, Bax:Bcl2↑, VEGF↓, Hif1a↓, Dose∅, GLUT1↓, GlucoseCon↓,
1547- Api,    Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading
- Review, NA, NA
angioG↓, EMT↓, CSCs↓, TumCCA↑, Dose∅, ROS↑, MMP↓, Catalase↓, GSH↓, PI3K↓, Akt↓, NF-kB↓, OCT4↓, Nanog↓, SIRT3↓, SIRT6↓, eff↑, eff↑, Cyt‑c↑, Bax:Bcl2↑, p‑GSK‐3β↓, FOXO3↑, p‑STAT3↓, MMP2↓, MMP9↓, COX2/PTGS2↓, MMPs↓, NRF2↓, HDAC↓, Telomerase↓, eff↑, eff↑, eff↑, eff↑, eff↑, XIAP↓, survivin↓, CK2↓, HSP90↓, Hif1a↓, FAK↓, EMT↓,
1536- Api,    Apigenin causes necroptosis by inducing ROS accumulation, mitochondrial dysfunction, and ATP depletion in malignant mesothelioma cells
- in-vitro, MM, MSTO-211H - in-vitro, MM, H2452
tumCV↓, ROS↑, MMP↓, ATP↓, Apoptosis↑, Necroptosis↑, DNAdam↑, TumCCA↑, Casp3↑, cl‑PARP↑, MLKL↑, p‑RIP3↑, Bax:Bcl2↑, eff↓, eff↓,
1367- Ash,    An anti-cancerous protein fraction from Withania somnifera induces ROS-dependent mitochondria-mediated apoptosis in human MDA-MB-231 breast cancer cells
- in-vitro, BC, MDA-MB-231
Apoptosis↑, ROS↑, Bax:Bcl2↑, MMP↓, Casp3↑, TumCCA↑,
5387- AsP,  PacT,    Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy
- in-vivo, Melanoma, B16-F10
Dose↝, TumCG↓, TumCP↓, BioAv↓, BioAv↑, other↑, Apoptosis↑, Bax:Bcl2↑, EPR↑, toxicity↝,
147- ATG,  EGCG,  CUR,    Increased chemopreventive effect by combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, MCF7
Bax:Bcl2↑, NF-kB↓, PI3K/Akt↓, STAT3↓, chemoPv↑, TumCP↓, TumCCA↑, TumCMig↓,
1053- Ba,  docx,    Baicalin, a Potent Inhibitor of NF-κB Signaling Pathway, Enhances Chemosensitivity of Breast Cancer Cells to Docetaxel and Inhibits Tumor Growth and Metastasis Both In Vitro and In Vivo
- in-vivo, BC, 4T1
TumCP↓, Apoptosis↑, ROS↑, Bax:Bcl2↑, NF-kB↓, ChemoSen↑, survivin↓,
5250- Ba,    Exploring baicalein: A natural flavonoid for enhancing cancer prevention and treatment
- Review, Var, NA
Apoptosis↑, TumAuto↑, DNAdam↑, *antiOx↑, Inflam↓, PGE2↓, TumCCA↑, TumCMig↓, TumCI↓, angioG↓, selectivity↑, ChemoSen↑, HIF-1↓, cMyc↓, NF-kB↓, VEGF↓, P53↑, MMP2↓, CSCs↓, Bcl-xL↓, XIAP↓, survivin↓, tumCV↓, Casp3↑, Casp8↑, Bax:Bcl2↑, Akt↓, mTOR↓, PCNA↓, MMP↓, ROS↑, PARP↑, Casp9↑, BioAv↑, eff↑, P-gp/ABCB1↓, BioAv↑, selectivity↑,
1528- Ba,    Inhibiting reactive oxygen species-dependent autophagy enhanced baicalein-induced apoptosis in oral squamous cell carcinoma
- in-vitro, OS, CAL27
Apoptosis↑, ROS↑, eff↓, TumAuto↑, cl‑PARP↑, Bax:Bcl2↑, Beclin-1/ATG6↑, p62↓,
2477- Ba,    Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells
- in-vitro, CRC, T24/HTB-9
TumCG↓, TumCCA↑, MMP↓, Cyt‑c↑, Casp9↑, Casp3↑, p‑Akt↓, Bcl-2↓, BAX↑, Bax:Bcl2↑, 12LOX↓,
2603- Ba,    Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
TumCG↓, Apoptosis↑, Cav1↓, p‑Akt↓, p‑mTOR↓, Bax:Bcl2↑, survivin↓, cl‑PARP↑, BioAv↓,
5547- BBM,    Berbamine exerts anticancer effects on human colon cancer cells via induction of autophagy and apoptosis, inhibition of cell migration and MEK/ERK signalling pathway
- in-vitro, CRC, HT29
tumCV↓, selectivity↑, Casp3↑, Casp9↑, Bax:Bcl2↑, ATG5↑, Beclin-1/ATG6↑, TumCP↓, MEK↓, ERK↓,
5551- BBM,    Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis
- vitro+vivo, Bladder, NA
tumCV↓, TumCP↓, TumCCA↑, P21↑, p27/CDKN1B↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK2↓, EMT↓, TumMeta↓, p65↓, p‑p65↓, IKKα↓, NF-kB↑, ROS↑, NRF2↓, HO-1↓, SOD2↓, GPx1↓, Bax:Bcl2↑, TumVol↓,
1299- BBR,    Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
- Review, NA, NA
TumCCA↑, TP53↑, COX2/PTGS2↓, Bax:Bcl2↑, ROS↑, VEGFR2/KDR/Flk1↓, Akt↓, ERK↓, MMP2↓, MMP9↓, IL8↑, P21↑, p27/CDKN1B↑, E-cadherin↓, Fibronectin↓, cMyc↓,
1377- BBR,    Berberine inhibits autophagy and promotes apoptosis of fibroblast-like synovial cells from rheumatoid arthritis patients through the ROS/mTOR signaling pathway
- in-vitro, Arthritis, NA
Apoptosis↑, MMP↓, Bax:Bcl2↑, LC3‑Ⅱ/LC3‑Ⅰ↓, p62↑, *ROS↓,
1402- BBR,    Berberine-induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and mitochondrial dysfunction
- in-vitro, GBM, T98G
tumCV↓, ROS↑, Ca+2↑, ER Stress↑, eff↓, Bax:Bcl2↑, MMP↓, Casp9↑, Casp3↑, cl‑PARP↑,
2685- BBR,    Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells
- in-vitro, neuroblastoma, NA
CSCs↓, CD133↓, β-catenin/ZEB1↓, n-MYC↓, SOX2↓, NOTCH2↓, Nestin↓, TumCCA↑, TumCP↓, CDK1↓, Cyc↓, Apoptosis↑, Bax:Bcl2↑, NCAM↓, MMP2↓, MMP9↓, *Smad1↑, *HSP70/HSPA5↑, *LAMs↑,
2686- BBR,    Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
- Review, Nor, NA
Inflam↓, IL6↓, MCP1/CCL2↓, COX2/PTGS2↓, PGE2↓, MMP2↓, MMP9↓, DNAdam↑, eff↝, Telomerase↓, Bcl-2↓, AMPK↑, ROS↑, MMP↓, ATP↓, p‑mTORC1↓, p‑S6K↓, ERK↓, PI3K↓, PTEN↑, Akt↓, Raf↓, MEK↓, Dose↓, Dose↑, selectivity↑, TumCCA↑, eff↑, EGFR↓, Glycolysis↓, Dose?, p27/CDKN1B↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Casp3↑, Casp9↑, VEGFR2/KDR/Flk1↓, ChemoSen↑, eff↑, eff↑, PGE2↓, JAK2↓, STAT3↓, CXCR4↓, CCR7↓, uPA↓, CSCs↓, EMT↓, Diff↓, CD133↓, Nestin↓, n-MYC↓, NOTCH↓, SOX2↓, Hif1a↓, VEGF↓, RadioS↑,
5178- BBR,    Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
TumCP↑, TumCCA↑, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓, CDK6↓, P21↑, p27/CDKN1B↑, Apoptosis↑, Bax:Bcl2↑, MMP↓, Casp9↑, Casp3↑, PARP↑, DNAdam↑, selectivity↑, Cyt‑c↑,
6496- BCP,    β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models
- vitro+vivo, CRC, HCT116 - in-vitro, Nor, HUVECs
angioG↓, VEGF↓, TumVol↓, Apoptosis↑, HSP60/HSPD1↓, HTRA↓, survivin↓, XIAP↓, P21↑, *toxicity↓, *neuroP↑, *ROS↓, *COX2/PTGS2↓, *Inflam↓, *cardioP↑, AntiCan↑, ChemoSen↑, ROS↑, MMP↑, Bax:Bcl2↑, TumCG↓,
6504- BCP,    β-Caryophyllene Induces PPARγ-Mediated Apoptosis and Enhances the Radiosensitivity in Colorectal Cancer Cells
- in-vitro, CRC, CT26 - in-vitro, CRC, HCT116
RadioS↑, TumCCA↑, γH2AX↑, DNAdam↑, p‑Akt↓, cycD1/CCND1↓, PPARγ↑, Bax:Bcl2↑, Casp3↑, Apoptosis↑,
2718- BetA,    The anti-cancer effect of betulinic acid in u937 human leukemia cells is mediated through ROS-dependent cell cycle arrest and apoptosis
- in-vitro, AML, U937
TumCCA↑, Apoptosis↑, i-ROS↑, cycA1/CCNA1↓, CycB/CCNB1↓, P21↑, Cyt‑c↑, MMP↓, Bax:Bcl2↑, Casp9↑, Casp3↑, PARP↓, eff↓, *antiOx↑, *Inflam↓, *hepatoP↑, selectivity↑, NF-kB↓, *ROS↓,
1450- Bos,  Cisplatin,    3-Acetyl-11-keto-β-boswellic acid (AKBA) induced antiproliferative effect by suppressing Notch signaling pathway and synergistic interaction with cisplatin against prostate cancer cells
- in-vitro, Pca, DU145
ROS↑, MMP↓, Casp↑, Apoptosis↑, Bax:Bcl2↑, TumCCA?, cycD1/CCND1↓, CDK4↓, P21↑, p27/CDKN1B↑, NOTCH↓, ChemoSen↑,
1651- CA,  PBG,    Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
- Review, Var, NA
Apoptosis↑, TumCCA↓, TumCMig↓, TumMeta↓, ChemoSen↑, eff↑, eff↑, eff↓, eff↝, Dose∅, AMPK↑, p62↓, LC3II↑, Ca+2↑, Bax:Bcl2↑, CDK4↑, CDK6↑, RB1↑, EMT↓, E-cadherin↑, Vim↓, β-catenin/ZEB1↓, NF-kB↓, angioG↑, VEGF↓, TSP-1↑, MMP9↓, MMP2↓, ChemoSen↑, eff↑, ROS↑, CSCs↓, Fas↑, P53↑, BAX↑, Casp↑, β-catenin/ZEB1↓, NDRG1↑, STAT3↓, MAPK↑, ERK↑, eff↑, eff↑, eff↑,
1297- CA,    Caffeic Acid Phenethyl Ester (CAPE) Induced Apoptosis in Serous Ovarian Cancer OV7 Cells by Deregulation of BCL2/BAX Genes
- in-vitro, Ovarian, OV7
lysosome↓, Apoptosis↑, Bax:Bcl2↑,
5750- CA,    Exploration of the anticancer properties of Caffeic Acid in malignant mesothelioma cells
- in-vitro, MM, NA
eff↑, selectivity↑, Ki-67↓, PCNA↓, TumCP↓, p‑ERK↓, Akt↓, p27/CDKN1B↑, P21↑, TumCCA↑, Bax:Bcl2↑, cl‑Casp3↑, mt-Apoptosis↑,
2019- CAP,    Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer
- Review, Var, NA
chemoPv↑, Ca+2↑, antiOx↑, *ROS↓, *MMP∅, *Cyt‑c∅, *Casp3∅, *eff↑, *Inflam↓, *NF-kB↓, *COX2/PTGS2↓, iNOS↓, TRPV1↑, i-Ca+2?, MMP↓, Cyt‑c↑, Bax:Bcl2↑, P53↑, JNK↑, PI3K↓, Akt↓, mTOR↓, LC3II↑, ATG5↑, p62↑, Fap1↓, Casp3↑, Apoptosis↑, ROS↑, MMP9↓, eff↑, eff↓, eff↑, selectivity↑, eff↑, ChemoSen↑,
5907- CAR,    Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2
- in-vitro, Liver, HepG2
TumCG↓, Apoptosis↓, Casp3↓, cl‑PARP↑, Bcl-2↓, p‑ERK↓, p‑p38↑, *Bacteria↓, *AntiAg↑, *Inflam↓, *antiOx↑, *AChE↓, AntiTum↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp↑, DNAdam↑, selectivity↑,
5897- CAR,    Carvacrol Selectively Induces Mitochondria-Related Apoptotic Signaling in Primary Breast Cancer-Associated Fibroblasts
- in-vitro, BC, NA
Bax:Bcl2↑, PPARα↓, NF-kB↓, SIRT1↑, SIRT3↑, MMP3↓, selectivity↑, Bcl-2↓, BAX↑, Casp3↑, Casp6↑, Casp9↑, mt-Apoptosis↑,
5895- CAR,    Carvacrol as a Therapeutic Candidate in Breast Cancer: Insights into Subtype-Specific Cellular Modulation
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
TumCG↓, TumCMig↓, Apoptosis↑, Bax:Bcl2↑, ROS↓, CD44↓, CSCs↓,
6615- Cen,    Asiaticoside suppresses cell proliferation by inhibiting the NF-κB signaling pathway in colorectal cancer
- vitro+vivo, CRC, HCT116 - in-vitro, CRC, SW480 - in-vitro, CRC, LoVo
Dose↝, TumCP↓, selectivity↑, MMP↓, Apoptosis↑, TumCCA↑, NF-kB↓, CDK4↓, cycD1/CCND1↓, Casp9↑, Casp3↑, Bax:Bcl2↑, TumCG↓, ChemoSen↑, TNF-α↓, IL1β↓, P53↑, P21↑,
6002- CGA,    Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials
- Review, Var, NA - Review, Diabetic, NA - Review, AD, NA - Review, Park, NA - Review, Stroke, NA
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2/PTGS2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *eff↑, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
6654- CGA,    Chlorogenic acid induces 4T1 breast cancer tumor's apoptosis via p53, Bax, Bcl-2, and caspase-3 signaling pathways in BALB/c mice
- in-vivo, BC, 4T1
TumW↓, TumVol↓, TumMeta↓, Bax:Bcl2↑, P53↑, Casp3↑,
6135- CHr,    Chrysin as a Multifunctional Therapeutic Flavonoid: Emerging Insights in Pathogenesis Management: A Narrative Review
- Review, Var, NA - Review, AD, NA
Inflam↓, angioG↓, Apoptosis↑, TumAuto↑, TumCCA↑, BioAv↓, Half-Life↓, BioAv↓, *ROS↓, *hepatoP↑, *RenoP↑, TET1↑, MMP9↓, cMyc↓, Ki-67↓, CBR1↓, ROS↑, ChemoSen↑, Bax:Bcl2↑, PUMA↑, NOTCH1↑, *AntiDiabetic↑, *neuroP↑, *GABA↑, *DNAdam↓, *BDNF↑, *memory↑, *AGEs↓, *Aβ↓, *cardioP↑, *AntiArt↑, eff↑, eff↑, *eff↑, RadioS↑, eff↑, ChemoSen↑, eff↑,
4772- CoQ10,    The anti-tumor activities of coenzyme Q0 through ROS-mediated autophagic cell death in human triple-negative breast cells
- in-vitro, BC, MDA-MB-468 - in-vitro, BC, MDA-MB-231
TumCP↓, Apoptosis↑, Casp3↑, cl‑PARP↑, LC3II↑, eff↓, TumCG↓, Bax:Bcl2↑, Beclin-1/ATG6↑, TumAuto↑, ROS↑,
4776- CoQ10,    Antitumor properties of Coenzyme Q0 against human ovarian carcinoma cells via induction of ROS-mediated apoptosis and cytoprotective autophagy
- vitro+vivo, Ovarian, SKOV3
ROS↑, eff↓, AntiCan↑, Apoptosis↑, tumCV↓, TumCG↓, TumCCA↑, LC3s↑, ERStress↑, Beclin-1/ATG6↑, Bax:Bcl2↑, HER2/EBBR2↓, Akt↓, mTOR↓,
6181- Cro,    Crocetin: A Systematic Review
- Review, Var, NA - Review, AD, NA
cardioP↑, hepatoP↑, *neuroP↑, AntiCan↑, *AntiDiabetic↑, *memory↑, *BioAv↓, *ROS↓, Apoptosis↑, *lipid-P↓, *SOD↑, SOD↓, ERα/ESR1↓, HDAC2↓, TumCCA↑, Bax:Bcl2↑, IL6↓, IL8↓, Shh↓, COX2/PTGS2↑, *GSK‐3β↓, *ERK↓, *tau↓, *ROS↓, *GSTs↑, *Catalase↑, *SOD↑, *BioAv↑,
6291- Cro,    Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model
- vitro+vivo, PC, MIA PaCa-2 - vitro+vivo, PC, Bxpc-3 - vitro+vivo, PC, Capan1 - vitro+vivo, PC, AsPC-1
TumCG↓, EGFR↓, Apoptosis↑, Bax:Bcl2↑, TumCP↓, TumCCA↑, Dose↝,

Showing Research Papers: 1 to 50 of 140
Page 1 of 3 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 140

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   CBR1↓, 1,   HES1↓, 1,   HSP60/HSPD1↓, 1,   HTRA↓, 1,   LIMK1↓, 1,   MMP16↓, 1,   RUBCN↓, 1,   THEM4/CTMP↑, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   ULK1/ATG1↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 3,   Catalase↓, 1,   Catalase↑, 1,   Fenton↑, 2,   Ferroptosis↑, 1,   GPx1↓, 1,   GSH↓, 9,   mt-GSH↓, 1,   GSH/GSSG↓, 1,   GSSG↑, 1,   HO-1↓, 3,   HO-1↑, 2,   HO-2↓, 1,   Iron↓, 1,   Iron↑, 1,   lipid-P↑, 1,   MDA↑, 3,   NRF2↓, 4,   NRF2↑, 4,   NRF2⇅, 1,   p‑NRF2↑, 1,   OSI↑, 1,   PARK2↑, 1,   PYCR1↓, 1,   ROS?, 1,   ROS↓, 11,   ROS↑, 64,   ROS⇅, 1,   i-ROS↑, 1,   mt-ROS↑, 1,   SIRT3↓, 1,   SIRT3↑, 2,   SOD↓, 5,   SOD↑, 1,   SOD2↓, 1,   SOD2↑, 1,   TAC↓, 1,   TBARS↑, 1,   TOS↑, 1,   Trx2↓, 1,   TrxR↓, 1,   TrxR1↓, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

STEAP3↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

AIF↑, 2,   ATP↓, 5,   CDC2↓, 2,   CDC25↓, 2,   CDC25↑, 1,   FGFR1↓, 1,   MEK↓, 4,   mitResp↓, 1,   MKK4↓, 1,   MMP↓, 52,   MMP↑, 1,   MPT↑, 2,   mtDam↑, 8,   OCR↓, 1,   PINK1↑, 1,   Raf↓, 2,   XIAP↓, 8,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   ALAT↓, 1,   AMPK↑, 6,   ATG7↑, 2,   CAIX/CA9↓, 1,   Cav1↓, 1,   CholSyn↓, 1,   cMyc↓, 15,   ECAR↝, 1,   FASN↓, 2,   GlucoseCon↓, 3,   Glycolysis↓, 7,   HK2↓, 4,   lactateProd↓, 1,   LDH↓, 2,   LDH↑, 1,   LDH↝, 1,   LDHA↓, 2,   NADPH↓, 1,   NADPH↑, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 1,   PI3K/Akt↓, 3,   PKM2↓, 2,   PKM2↑, 1,   PPARα↓, 1,   PPARγ↑, 4,   PPP↓, 1,   p‑S6K↓, 1,   SIRT1↓, 2,   SIRT1↑, 1,   TS↓, 1,  

Cell Death(tgid=5) ⓘ

Akt↓, 33,   Akt↑, 2,   p‑Akt↓, 17,   APAF1↑, 3,   Apoptosis↓, 2,   Apoptosis↑, 88,   mt-Apoptosis↑, 3,   BAD↓, 2,   BAD↑, 1,   BAX↑, 19,   Bax:Bcl2↑, 140,   Bcl-2↓, 24,   Bcl-xL↓, 7,   BMP2↓, 1,   Casp↑, 10,   Casp12?, 1,   Casp12↑, 3,   Casp3?, 1,   Casp3↓, 2,   Casp3↑, 66,   cl‑Casp3↑, 13,   proCasp3↓, 1,   Casp6↑, 1,   Casp7↑, 5,   cl‑Casp7↑, 1,   Casp8↑, 12,   Casp8∅, 2,   cl‑Casp8↑, 1,   Casp9↓, 1,   Casp9↑, 42,   cl‑Casp9↑, 8,   proCasp9↓, 1,   Chk2↑, 1,   CK2↓, 4,   Cyt‑c↓, 1,   Cyt‑c↑, 43,   Diablo↑, 2,   DR4↑, 2,   DR5↑, 4,   FADD↑, 1,   Fap1↓, 1,   Fas↓, 1,   Fas↑, 5,   FasL↑, 2,   Ferroptosis↑, 1,   hTERT/TERT↓, 4,   IAP1↓, 4,   IAP2/BIRC3↓, 3,   cl‑IAP2/BIRC3↑, 1,   iNOS↓, 3,   JNK↑, 3,   p‑JNK↓, 3,   MAPK↓, 3,   MAPK↑, 3,   Mcl-1?, 1,   Mcl-1↓, 1,   MDM2↓, 4,   MLKL↑, 1,   Myc↓, 1,   Necroptosis↑, 1,   necrosis↑, 1,   NOXA↑, 1,   p27/CDKN1B↑, 15,   p38↓, 2,   p38↑, 4,   p‑p38↑, 2,   PUMA↑, 2,   Pyro↑, 1,   survivin↓, 16,   Telomerase↓, 8,   TRAIL↑, 2,   TRPV1↑, 1,   TRPV1↝, 1,   TumCD↑, 2,   β-TRCP↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

AMPKα↓, 1,   HER2/EBBR2↓, 4,   p70S6↓, 1,   Sp1/3/4↓, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ChrMod↝, 1,   cJun↓, 1,   cJun↑, 1,   HATs↓, 2,   miR-21↓, 1,   other↑, 1,   other↝, 3,   PCAF↓, 1,   p‑pRB↓, 1,   tumCV?, 1,   tumCV↓, 24,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 4,   eIF2α↓, 1,   ER Stress↑, 8,   ERStress↑, 1,   HSP90↓, 2,   HSPs↓, 1,   PERK↑, 1,   UPR↑, 2,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 5,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 8,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↑, 6,   LC3s↑, 1,   lysosome↓, 1,   MitoP↑, 1,   p62↓, 3,   p62↑, 5,   TumAuto↑, 12,  

DNA Damage & Repair(tgid=10) ⓘ

DFF45↑, 1,   DNA-PK↑, 1,   DNAdam↓, 2,   DNAdam↑, 22,   mt-DNAdam↑, 1,   DNMTs↓, 1,   MGMT↓, 1,   NKX3.1↑, 1,   p16↑, 1,   P53↓, 1,   P53↑, 25,   P53∅, 1,   p‑P53↑, 1,   PARP↓, 1,   PARP↑, 3,   p‑PARP↑, 2,   cl‑PARP↓, 1,   cl‑PARP↑, 35,   cl‑PARP1↑, 1,   PCNA↓, 6,   SIRT6↓, 1,   SIRT6↑, 1,   TP53↑, 1,   γH2AX↑, 3,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 5,   CDK2↓, 8,   CDK4↓, 13,   CDK4↑, 1,   Cyc↓, 1,   cycA1/CCNA1↓, 4,   CycB/CCNB1↓, 5,   cycD1/CCND1↓, 29,   CycD3↓, 1,   cycE/CCNE↓, 6,   mitA↑, 1,   p19↑, 1,   P21↓, 1,   P21↑, 31,   RB1↑, 1,   p‑RB1↓, 1,   TumCCA?, 2,   TumCCA↓, 2,   TumCCA↑, 63,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   CD133↓, 3,   CD44↓, 6,   cDC2↓, 1,   CDK8↓, 1,   cFos↓, 2,   CIP2A↓, 1,   p‑cMET↑, 1,   cMYB↓, 1,   CREB2↓, 1,   CSCs↓, 13,   Diff↓, 1,   Diff↑, 1,   EMT↓, 15,   EMT↝, 1,   ERK↓, 11,   ERK↑, 5,   p‑ERK↓, 6,   p‑ERK↑, 1,   p‑ERK⇅, 1,   e-ERK↑, 1,   FGF↓, 1,   FOXM1↓, 1,   FOXO3↓, 1,   FOXO3↑, 3,   FOXO4↑, 2,   Gli↓, 1,   Gli1↓, 1,   GSK‐3β↓, 2,   GSK‐3β↑, 1,   p‑GSK‐3β↓, 5,   HDAC↓, 7,   HDAC1↓, 2,   HDAC2↓, 1,   HDAC3↓, 2,   HH↓, 3,   HMGCR↓, 1,   IGF-1↓, 2,   IGFBP3↑, 1,   p‑Jun↓, 1,   miR-34a↓, 1,   miR-34a↑, 1,   mTOR↓, 10,   p‑mTOR↓, 6,   p‑mTORC1↓, 1,   n-MYC↓, 2,   Nanog↓, 3,   Nestin↓, 2,   NOTCH↓, 4,   NOTCH1↓, 1,   NOTCH1↑, 1,   NOTCH2↓, 1,   OCT4↓, 2,   p300↓, 1,   P70S6K↓, 1,   PI3K↓, 21,   p‑PI3K↓, 2,   PTEN↑, 4,   p‑PTEN↓, 1,   RAS↓, 1,   SCF↓, 1,   Shh↓, 2,   SOX2↓, 3,   Src↓, 1,   STAT3↓, 15,   p‑STAT3↓, 4,   p‑STAT3↑, 1,   STAT6↓, 1,   TOP2↓, 1,   TumCG↓, 29,   Wnt↓, 3,   Wnt↑, 1,   Wnt/(β-catenin)↓, 3,  

Migration(tgid=13) ⓘ

5LO↓, 1,   AntiAg↑, 1,   APC↑, 1,   Ca+2↑, 10,   Ca+2↝, 1,   i-Ca+2?, 1,   cal2↑, 2,   CLDN1↑, 1,   E-cadherin↓, 2,   E-cadherin↑, 7,   F-actin↓, 1,   FAK↓, 4,   p‑FAK↓, 2,   p‑FAK↑, 1,   Fibronectin↓, 1,   ITGB4↓, 1,   Ki-67↓, 6,   miR-148a↓, 1,   miR-19b↓, 1,   miR-200c↑, 1,   miR-384↑, 1,   MMP-10↓, 1,   MMP1↓, 1,   MMP2↓, 19,   MMP3↓, 3,   MMP7↓, 2,   MMP9↓, 21,   MMPs↓, 5,   MUC4↓, 1,   N-cadherin↓, 3,   NCAM↓, 1,   PKCδ↓, 2,   p‑RIP3↑, 1,   SMAD3↓, 2,   Snail↓, 1,   SOX4↓, 1,   TET1↑, 1,   TGF-β↓, 3,   TIMP1↑, 1,   TIMP2↓, 1,   TIMP2↑, 2,   TJ↑, 1,   TSC1↑, 1,   TSP-1↑, 1,   TumCA↓, 1,   TumCI↓, 13,   TumCMig↓, 18,   TumCMig↑, 1,   TumCP↓, 38,   TumCP↑, 1,   TumCP∅, 1,   TumMeta↓, 10,   Twist↓, 2,   uPA↓, 2,   VEGFR1↓, 2,   Vim↓, 2,   ZO-1↑, 1,   β-catenin/ZEB1↓, 13,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 21,   angioG↑, 1,   ATF4↑, 1,   EGFR↓, 11,   Endoglin↑, 1,   EPR↑, 1,   HIF-1↓, 2,   Hif1a↓, 12,   miR-34b-5p↑, 1,   NO↓, 1,   NO↑, 1,   VEGF↓, 25,   VEGF↑, 1,   VEGFR2/KDR/Flk1↓, 3,  

Barriers & Transport(tgid=15) ⓘ

BBB∅, 1,   CellMemb↑, 1,   GLUT1↓, 5,   GLUT4↓, 2,   IBI↑, 1,   NHE1↓, 1,   OCLN↑, 1,   P-gp/ABCB1↓, 4,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   COX1↓, 1,   COX2/PTGS2↓, 17,   COX2/PTGS2↑, 1,   CXCR4↓, 1,   IFN-γ↑, 1,   IKKα↓, 1,   IL10↑, 1,   IL1β↓, 3,   IL2↑, 2,   IL6↓, 5,   IL8↓, 2,   IL8↑, 1,   Imm↑, 1,   Imm↝, 1,   Inflam↓, 7,   IκB↓, 1,   JAK↓, 1,   JAK2↓, 2,   M2 MC↓, 1,   MCP1/CCL2↓, 2,   NF-kB↓, 39,   NF-kB↑, 1,   p‑NF-kB↓, 1,   NK cell↑, 1,   p65↓, 1,   p‑p65↓, 1,   PD-L1↓, 3,   PGE2↓, 3,   PSA↓, 2,   TNF-α↓, 6,  

Cellular Microenvironment(tgid=17) ⓘ

pH↓, 1,  

Protein Aggregation(tgid=19) ⓘ

PP2A↑, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 5,   CDK6↓, 5,   CDK6↑, 1,   COMT↓, 2,   ER(estro)↓, 1,   ERα/ESR1↓, 1,   ERβ/ESR2↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 1,   BioAv↓, 5,   BioAv↑, 7,   BioAv↝, 1,   BioEnh↑, 2,   chemoR↓, 1,   ChemoSen↑, 29,   Dose?, 2,   Dose↓, 1,   Dose↑, 1,   Dose↝, 6,   Dose∅, 5,   eff↓, 23,   eff↑, 49,   eff↝, 4,   eff∅, 1,   Half-Life↓, 2,   Half-Life↝, 1,   MDR1↓, 3,   MDR1↑, 1,   MRP1/ABCC1↓, 1,   RadioS↑, 12,   selectivity↑, 27,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   ALP↓, 2,   AR↓, 5,   AST↓, 1,   EGFR↓, 11,   ERα/ESR1↓, 1,   FOXM1↓, 1,   GutMicro↑, 1,   GutMicro↝, 1,   HER2/EBBR2↓, 4,   hTERT/TERT↓, 4,   IL6↓, 5,   Ki-67↓, 6,   LDH↓, 2,   LDH↑, 1,   LDH↝, 1,   Myc↓, 1,   PD-L1↓, 3,   PSA↓, 2,   TP53↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 13,   antiNeop↑, 3,   AntiTum↑, 3,   cardioP↑, 1,   chemoP↑, 3,   chemoPv↑, 9,   ChemoSideEff↓, 4,   hepatoP↑, 4,   NDRG1↑, 1,   OS↑, 2,   Pain↓, 1,   PRAS40↓, 1,   PRAS40↑, 1,   toxicity↓, 1,   toxicity↝, 2,   TumVol↓, 5,   TumVol↑, 1,   TumW↓, 4,  
Total Targets: 515

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

Mucositis↓, 1,   NeuroI↓, 1,   PLA2↓, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 10,   Catalase↑, 5,   Ferroptosis↓, 1,   GPx↑, 1,   GPx4↑, 1,   GSH↑, 4,   GSSG↓, 1,   GSTs↑, 3,   H2O2↑, 1,   HO-1↑, 3,   i-Iron↓, 1,   lipid-P↓, 3,   MDA↓, 8,   NRF2↑, 4,   ROS↓, 13,   SOD↑, 7,   Trx1↑, 1,   xCT/SLC7A11↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

MMP∅, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ALAT↓, 2,   AMPK↑, 1,   glucose↓, 1,   LDH↓, 2,   PPARα↝, 1,  

Cell Death(tgid=5) ⓘ

Akt↑, 3,   Bcl-2↑, 1,   Casp↓, 1,   Casp3↓, 1,   Casp3∅, 1,   Cyt‑c∅, 1,   Ferroptosis↓, 1,   JNK↓, 2,   MAPK↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

HSP70/HSPA5↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ERK↓, 2,   GSK‐3β↓, 1,   mTOR↑, 1,   PI3K↑, 3,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,   Ca+2↓, 1,   LAMs↑, 1,   LRP1↑, 1,   MUC1↑, 1,   PKCδ↓, 1,   RAGE↓, 1,   Smad1↑, 1,   TGF-β↓, 1,   TRPC1↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   Hif1a↓, 1,  

Barriers & Transport(tgid=15) ⓘ

IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX2/PTGS2↓, 4,   IL1↓, 1,   IL10↓, 1,   IL10↑, 1,   IL12↓, 1,   IL1β↓, 1,   IL4↓, 1,   IL5↓, 1,   IL6↓, 2,   Imm⇅, 1,   Inflam↓, 10,   NF-kB↓, 4,   PGE2↓, 1,   TLR4↓, 1,   TNF-α↓, 3,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 2,   BDNF↑, 1,   GABA↑, 1,   tau↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 3,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 6,   BioAv↑, 3,   ChemoSen↑, 1,   eff↑, 7,   Half-Life∅, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   AST↓, 2,   BMD↑, 1,   BP↓, 1,   GutMicro↑, 1,   IL6↓, 2,   LDH↓, 2,   RAGE↓, 1,  

Functional Outcomes(tgid=23) ⓘ

antiAll↑, 1,   AntiArt↑, 2,   AntiDiabetic↑, 5,   AntiP↑, 1,   cardioP↑, 5,   CardioT↓, 1,   chemoPv↑, 1,   cognitive↑, 1,   hepatoP↑, 5,   memory↑, 4,   neuroP↑, 8,   Obesity↓, 1,   radioP↑, 2,   RenoP↑, 3,   toxicity↓, 9,   toxicity↑, 1,   toxicity∅, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiViral↑, 2,   Bacteria↓, 2,   Sepsis↓, 1,  
Total Targets: 112

Scientific Paper Hit Count for: Bax:Bcl2, Bax:Bcl2 ratio
8 Thymoquinone
7 Apigenin (mainly Parsley)
6 Berberine
6 Lycopene
6 Sulforaphane (mainly Broccoli)
5 Baicalein
4 Quercetin
4 Emodin
3 EGCG (Epigallocatechin Gallate)
3 Curcumin
3 Caffeic acid
3 Carvacrol
3 Crocetin
3 Ellagic acid
3 Formononetin
3 Garcinol
3 iodine
3 Ivermectin
3 Luteolin
2 Cisplatin
2 Silver-NanoParticles
2 Arctigenin
2 Docetaxel
2 Berbamine
2 Beta-Caryophyllene
2 Propolis -bee glue
2 Chlorogenic acid
2 Coenzyme Q10
2 Dandelion Root
2 Gambogic Acid
2 Graviola
2 HydroxyTyrosol
2 isoorientin
2 Licochalcone A
2 Myricetin
1 2-DeoxyGlucose
1 Astragalus
1 Allicin (mainly Garlic)
1 Alpha-Lipoic-Acid
1 Andrographis
1 Anethole/trans-Anethole
1 Fennel Oil/Foeniculum vulgare
1 Ashwagandha(Withaferin A)
1 Ascorbyl Palmitate
1 Paclitaxel/Taxol
1 Betulinic acid
1 Boswellia (frankincense)
1 Capsaicin
1 Centella asiatica / Gotu kola → asiaticoside
1 Chrysin
1 Cynara scolymus/Globe Artichoke/Artichoke Extract
1 Copper and Cu NanoParticles
1 Diclofenac
1 D-limonene
1 Radiotherapy/Radiation
1 Ferulic acid
1 Fenbendazole
1 Fucoidan
1 Gallic acid
1 Ginkgolic acids
1 Ginkgo biloba
1 Ginkgetin
1 Hydroxycinnamic-acid
1 Hyperoside
1 Isoliquiritigenin
1 isoquercitrin
1 Juglone
1 Kaempferol
1 Magnolol
1 Magnetic Fields
1 Nimbolide
1 Plumbagin
1 Rosmarinic acid
1 salinomycin
1 Terpinen-4-ol / Tea Tree Oil
1 doxorubicin
1 Thymol-Thymus vulgaris
1 Vitamin D3
1 Melatonin
1 Vitexin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:352  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page